| Financial Year |
March 31 2023 |
| Monetary Funds |
2,260,291,120.47 |
| Held-for-trading Financial Assets |
510,098,236.88 |
| Notes Receivable |
-- |
| Accounts Receivable |
525,443,567.76 |
| Advances to Suppliers |
17,089,758.00 |
| Other Receivables |
35,772,389.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,441,201,086.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
112,484,156.82 |
| Total Current Assets |
7,069,791,127.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
155,192,736.88 |
| Investment Properties |
5,050,663.84 |
| Fixed Assetes |
14,990,307.30 |
| Under-construction Projects |
532,561,300.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
397,827,620.22 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
45,002,693.88 |
| Deferred Income Tax Assets |
144,304,675.42 |
| Other Non-Current Assets |
1,450,067.52 |
| Sub-Total of Non-Current Assets |
1,391,911,122.53 |
| Total Assets |
8,461,702,249.78 |
| Short-Term Loans |
400,317,777.79 |
| Trading Financial liabilities |
625,867,350.64 |
| Notes Payable |
-- |
| Accounts Payable |
202,509,771.85 |
| Accounts Received In Advance |
58,036,758.74 |
| Employee Compensation Payable |
23,968,721.96 |
| Taxes Payable |
199,120,616.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
380,072,622.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,167,398.63 |
| Other Current Liabilities |
9,462,413.71 |
| Sub-Total of Current Liabilities |
1,972,343,754.19 |
| Long-term Loans |
18,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,162,400.65 |
| Deferred Income Tax Liabilities |
257.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
75,915,597.94 |
| Total Liabilities |
2,048,259,352.13 |
| Paid-In Capital(Or Share Stock) |
1,095,926,265.00 |
| Capital Surplus |
1,327,358,286.18 |
| Surplus Reserve |
548,231,886.71 |
| LESS:Treasury Stock |
169,991,178.76 |
| Undistributed Profits |
3,921,995,497.85 |
| Minority Stockholder's Interest |
5,802,910.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,407,639,987.27 |
| Owner's Equity（Stockholder's Equity） |
6,413,442,897.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,461,702,249.78 |
